Pursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI Listing Regulations''), we hereby inform you that the Board of ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025. Standalone revenue declined to Rs. 10,299.50 lakhs (from Rs. 10,806.44 lakhs in FY24), while standalone PAT rose modestly to Rs. 368.05 lakhs (from Rs. 308.81 lakhs). Consolidated PAT nearly doubled to Rs. 953.13 lakhs (from Rs. 492.50 lakhs), helped by Rs. 585.05 lakhs share of profit from associates. Q4 standalone numbers were weak, posting a loss of Rs. 962.85 lakhs at the PAT level. Non-current borrowings jumped sharply from Rs. 1,634.17 lakhs to Rs. 4,623.55 lakhs, boosting cash and equivalents to Rs. 5,150.33 lakhs. The auditor (M/s Saha & Majumder) issued an unmodified opinion. The Board also approved re-appointment of Mr. Ajit Kumar Agarwala as Managing Director for 3 years from August 12, 2025, and re-appointed Secretarial, Internal and Cost Auditors.
Mixed signals for shareholders – consolidated earnings improved sharply driven by associate companies, but standalone core tea operations saw a revenue dip and a quarterly loss, alongside a large increase in borrowings. The MD continuation provides leadership stability, while the clean audit opinion removes a key governance overhang.